Expression of CCL2 has also been found to be decreased in prostate adenocarcinoma compared to benign prostate hyperplasia (Mazzucchelli et al, 1996) and cervical carcinomas compared to normal or hyperplastic squamous epithelium (Riethdorf et al, 1998; Kleine-Lowinski et al, 1999). The gene discussed is CCL2; the disease is benign prostatic hyperplasia.